We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0Q6H market cap is 822.16M. The company's latest EPS is NOK -0.3048 and P/E is -6.56.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 69.25M | 87.62M | 122.33M | 218.51M | 265.54M |
| Operating Income | -92.81M | -118.53M | -128.82M | -88.17M | -91.88M |
| Net Income | -102.09M | -126.46M | -137.39M | -106.68M | -125.3M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 459.13M | 415.97M | 411.03M | 390.12M | 339.42M |
| Total Liabilities | 195.37M | 275.6M | 263M | 348.98M | 280.07M |
| Total Equity | 263.76M | 140.38M | 148.03M | 41.14M | 59.36M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -61.63M | -61.78M | -45.17M | 2.76M | -9.78M |
| Investing | -60.06M | -37.94M | -17.78M | -14.99M | -4.07M |
| Financing | 199.97M | -23.2M | 45.45M | 3.69M | 15.54M |
| Market Cap | 822.16M |
| Price to Earnings Ratio | -6.56 |
| Price to Sales Ratio | 3.1 |
| Price to Cash Ratio | 32.15 |
| Price to Book Ratio | 13.85 |
| Dividend Yield | - |
| Shares Outstanding | 411.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 331 |
| 52 Week Change | 0.00% |
| 52 Week High | 2.00 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Hofseth Biocare Asa |
| Address |
havnegata 11 alesund 6005 |
| Website | https://www.hofsethbiocare.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
